Here’s the latest high-level update on the Novo Nordisk Foundation based on recently reported activity.
- The Foundation marked its 100th anniversary in 2024 and reached a milestone in grant activity, awarding around DKK 10.1 billion (€1.35 billion) that year to support nearly 1,800 projects spanning health, sustainability, and bioeconomy initiatives. This was the first time annual grants exceeded DKK 10 billion, reflecting expanded international collaboration and greater geographic reach beyond Denmark.[1][2]
- Key focus areas in 2024 included cardiometabolic disease research, antimicrobial resistance initiatives (including CARB-X collaborations), regenerative medicine, and early-stage biosolutions, with notable programs like BRIGHT at DTU and the Best for Us mental health initiative for youth.[2][3]
- In 2025, the Foundation continued extending its Challenge Programme and international collaborations, with efforts to invite researchers beyond Denmark and broaden access to funding across Europe and the UK, signaling sustained growth in grant-giving capacity and global partnerships.[4]
If you’d like, I can pull the most current press statements or provide a short, cited summary with direct quotes from the Foundation’s latest news releases. Would you prefer a focused update on a particular area (e.g., antimicrobial resistance, mental health, or regenerative medicine) or a timeline of major milestones since 2024?
Citations:
- Novo Nordisk Foundation grant magnitude and 2024 milestones.[2]
- 2024 grant themes and leadership commentary.[1]
- Expansion of international collaboration and Challenge Programme updates.[4]